常茂生物(00954.HK)常州廠房因規劃需搬遷
常茂生物(00954.HK)公布,與濱江開發區的政府部門人員官員最近的討論,根據常州市及濱江開發區對長江沿岸最新規劃調整的規定,將對在長江沿岸地區生產部份化工產品施加限制。
集團位於常州濱江開發區的生產工廠其中一部份,目前涉及順酐及部份食品添加劑的生產,位於長江沿岸一公里以內,屬規劃調整範圍。新規定中的限制將適用於集團在常州一期廠房的生產。公司需於年底前,搬遷常州一期廠房的生產線;在長江沿岸地區停止生產被分類為化工類(危化品)的順酐。集團自願於6月停止生產順酐。在停止生產順酐之前,集團在常州一期廠房生產了部份供其他產品作原材料的的順酐。自常州一期廠房停止生產順酐後,集團需全部從第三方購買順酐。
據董事會所知並基於過去的經驗,順酐的供應在市場上容易獲得,採購成本不會比集團的內部生產成本高出很多。
另外,集團計劃將上述產品的生產線遷至位於長江一公里外的常州二期廠房。公司預計,此搬遷將需要大約二至三個月的時間。一旦獲得有關中國政府機構的批准,集團將開始進行搬遷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.